Filing Details
- Accession Number:
- 0001708138-19-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-12 16:05:13
- Reporting Period:
- 2019-11-08
- Accepted Time:
- 2019-11-12 16:05:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226689 | Neil Stahl | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-05-24 | 1,300 | $0.00 | 21,150 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2019-11-08 | 100 | $330.56 | 29,719 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 200 | $333.32 | 29,519 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 100 | $334.66 | 29,419 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 400 | $335.45 | 29,019 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 500 | $336.73 | 28,519 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 1,500 | $337.41 | 27,019 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 1,100 | $338.54 | 25,919 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 1,100 | $339.53 | 24,819 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 2,064 | $340.48 | 22,755 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-08 | 300 | $341.38 | 22,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,736 | Indirect | By 401(k) Plan |
| Common Stock | 7,831 | Indirect | by 2018 GRAT |
Footnotes
- Represents volume-weighted average price of sales of 200 shares of Company stock on November 8, 2019 at prices ranging from $333.31 to $333.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 100 shares of Company stock on November 8, 2019 at prices ranging from $334.48 to $334.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 400 shares of Company stock on November 8, 2019 at prices ranging from $335.02 to $335.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 500 shares of Company stock on November 8, 2019 at prices ranging from $336.48 to $336.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 1,500 shares of Company stock on November 8, 2019 at prices ranging from $337.03 to $337.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 8, 2019 at prices ranging from $338.10 to $338.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 8, 2019 at prices ranging from $339.05 to $339.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 2,064 shares of Company stock on November 8, 2019 at prices ranging from $340.00 to $340.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
- Represents volume-weighted average price of sales of 300 shares of Company stock on November 8, 2019 at prices ranging from $341.09 to $341.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2019 at each separate price.
Billionaire Hedge Funds
